We publish no single base value for Ameriprise Financial. Our valuation methods put it between $439.77 and $1,333.39 a share. The valuation code's reason: no point fair value: the two anchors behind it compound the same growth rate and differ only in how they end — a perpetuity at the terminal rate against a multiple on the final year — so the midpoint between them measures terminal treatment rather than what the business is worth. The published range is the same reading with the false precision removed: read it as the span the method supports, and treat neither edge as a point estimate.
| Method | Value | vs price | Basis |
|---|---|---|---|
| Discounted cash flow | $1,333.39 | +159.7% | free cash flow $7.38bn, growth 6.1% for 5 years, then fading to 3% over 5 more, discounted at 10.66%; plus net cash $35.91 a share; stress floor $898.87 |
| Exit multiple (P/E) | $439.77 | -14.4% | earnings per share $46.08 valued at 12.58× (the stock's own median P/E) in 5 years, discounted back |
| Sum of the parts | — | — | no sum of the parts: this run holds no segment disclosure for the name |
| Price to sales | — | — | not reached: the cash-flow or earnings methods produced an anchor, so this fallback was not run |
| Tangible book | — | — | used only for lenders, where book value is the business |
| Price to FFO (REITs) | — | — | used only for REITs |
Each working is rebuilt by code from the valuation's own figures and checked against the published value.
The discount rate:
| Risk-free rate | 5.13% (10-year US Treasury yield) |
| Company's own beta | 1.13 (5 years of monthly returns against the S&P 500; standard error 0.17) |
| Peer beta | 1.49 (median of 11 S&P 500 Asset Management & Custody Banks companies) |
| Blend of own and peers | 1.34 (41% own, 59% peers, weighted by how precisely the company's own beta is measured) |
| Adjusted beta | 1.23 (0.67 × 1.34 + 0.33, pulled toward the market's 1.0) |
| Equity risk premium | 4.5% |
| Discount rate = risk-free + adjusted beta × premium | 10.66% |
Free cash flow grows 6.10% a year for 5 years, then fades in equal steps toward 3% over 5 more; each year is discounted by 1 ÷ (1 + rate)^year:
| Year | Growth | Free cash flow | Discount factor | Present value |
|---|---|---|---|---|
| Now | — | $7.38bn | — | — |
| Year 1 | 6.10% | $7.83bn | 0.9036 | $7.08bn |
| Year 2 | 6.10% | $8.31bn | 0.8165 | $6.78bn |
| Year 3 | 6.10% | $8.82bn | 0.7379 | $6.50bn |
| Year 4 | 6.10% | $9.35bn | 0.6667 | $6.24bn |
| Year 5 | 6.10% | $9.92bn | 0.6025 | $5.98bn |
| Year 6 | 5.58% | $10.48bn | 0.5444 | $5.70bn |
| Year 7 | 5.07% | $11.01bn | 0.4920 | $5.42bn |
| Year 8 | 4.55% | $11.51bn | 0.4445 | $5.12bn |
| Year 9 | 4.03% | $11.97bn | 0.4017 | $4.81bn |
| Year 10 | 3.52% | $12.40bn | 0.3630 | $4.50bn |
| Terminal value = year-10 cash flow × (1 + 3%) ÷ (10.66% − 3%) | $166.57bn |
| Terminal value in today's money | $60.46bn |
| Present value of years 1–10 | $58.13bn |
| Total present value | $118.59bn |
| Shares outstanding | 91.40m |
| Cash flows per share = total ÷ shares | $1,297.49 |
| Plus net cash per share | $35.91 |
| Value per share | $1,333.39 |
How the DCF value moves with the discount rate and the starting growth (the middle cell is the published value):
| Discount rate | Growth 1.1% | Growth 6.1% | Growth 11.1% |
|---|---|---|---|
| 9.66% | $1,150.63 | $1,535.28 | — |
| 10.66% | $1,008.26 | $1,333.40 | — |
| 11.66% | $898.62 | $1,178.40 | — |
The same DCF at each beta, starting growth unchanged:
| Beta | Value | Discount rate | DCF value |
|---|---|---|---|
| Company's own beta | 1.13 | 10.21% | $1,417.27 |
| Peer beta | 1.49 | 11.84% | $1,155.57 |
| Adjusted beta (used) | 1.23 | 10.66% | $1,333.40 |
Earnings per share grow on the same fading path as the DCF:
| Year | Growth | Earnings per share |
|---|---|---|
| Now | — | $46.08 |
| Year 1 | 6.10% | $48.89 |
| Year 2 | 5.17% | $51.42 |
| Year 3 | 4.52% | $53.75 |
| Year 4 | 4.06% | $55.93 |
| Year 5 | 3.74% | $58.02 |
| Earnings per share in year 5 | $58.02 |
| Exit P/E (the stock's own median P/E) | 12.58× |
| Value in 5 years = earnings × P/E | $729.93 |
| Discounted at 10.66% over 5 years: ÷ 1.6598 | $439.77 |
We publish no single base value for Ameriprise Financial. Our valuation methods put it between $439.77 and $1,333.39 a share. The valuation code's reason: no point fair value: the two anchors behind it compound the same growth rate and differ only in how they end — a perpetuity at the terminal rate against a multiple on the final year — so the midpoint between them measures terminal treatment rather than what the business is worth. The published range is the same reading with the false precision removed: read it as the span the method supports, and treat neither edge as a point estimate.
One-year price simulation: a 10% chance the price is below $391.49 and a 10% chance it is above $773.85 in a year; a 61% chance it is higher than today's $513.48, from 26.45% volatility. The simulation assumes the price drifts up at our discount rate of 10.66% a year.
At $513.48 the price implies free cash flow growing -11.3% a year for five years and then fading toward 3% over five more; its revenue has grown 6.1%.
| Week | Price | Base value |
|---|---|---|
| 2 Oct 2026 | $490.91 | $495.64 |
| 9 Oct 2026 | $500.51 | $494.52 |
| 16 Oct 2026 | $500.80 | $523.86 |
| 23 Oct 2026 | $492.19 | $525.79 |
| 30 Oct 2026 | $490.83 | — |
| 6 Nov 2026 | $501.49 | — |
| 12 Nov 2026 | $513.48 | — |
Data as of 12 Nov 2026; financials to 30 Sep 2026. Sources: company filings via EODHD, SEC EDGAR, US Treasury. How these values are computed. Not investment advice.
Run a full Desk Run on AMP · Ameriprise Financial company page · Call and put prices